AAM Report: Generics and Biosimilars Generate $408 Billion in 2022 : vimarsana.com

A report from the Association for Accessible Medicines (AAM) highlighted the value of biosimilars and generics, revealing that lower-cost versions of originator products accumulated $408 billion for the US health care system in 2022.

Related Keywords

Texas , United States , West Virginia , Kentucky , Georgia , Wyoming , Louisiana , Vermont , California , New York , Alaska , Indiana , American , America , David Gaugh , Association For Accessible Medicines , American Journal , Accessible Medicines , Biosimilar Medicines Savings Report , Hatch Waxman Act , Biosimilars , Generics , Medicare , Savings ,